Skip to main content
Clinical Trials/NCT01200979
NCT01200979
Completed
Not Applicable

Assessment of Alterations in Immune Function During Pregnancy and Post Parturition

National Institute of Allergy and Infectious Diseases (NIAID)1 site in 1 country41 target enrollmentSeptember 30, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pregnancy Immune Function
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Enrollment
41
Locations
1
Primary Endpoint
Changes in Cytokine profiles during pregnancy
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Traditionally, it has been suggested that pregnancy causes an immunosuppressive state that would facilitate fetal tolerance and result in an increased susceptibility to infection. Although the suppression has been characterized as a global T-cell defect, the observation that the increase in susceptibility is restricted only to specific intracellular bacteria and viruses is consistent with a down regulation of only certain components of the innate immune system. Progress in the treatment and management of infections during pregnancy will require further understanding of the changes to the immune system that occur during pregnancy. It is hypothesized that there is a fundamental down-regulation in the innate immune system that occurs during pregnancy and remains until delivery and that changes in serum cytokines influence na(SqrRoot) ve CD4 differentiation to different subpopulations. To that end, this study will evaluate blood samples drawn from pregnant women during early, mid, and late pregnancy and post-partum for changes in the innate immune system and compare them to those of healthy, non-pregnant women. Changes in the cytokine profile and in the lymphocyte and natural killer (NK) cell populations will be identified. A comparison of any observed changes will be made with those previously reported for in vitro and in vivo studies.

Detailed Description

Traditionally, it has been suggested that pregnancy causes an immunosuppressive state that would facilitate fetal tolerance and result in an increased susceptibility to infection. Although the suppression has been characterized as a global T-cell defect, the observation that the increase in susceptibility is restricted only to specific intracellular bacteria and viruses is consistent with a down regulation of only certain components of the innate immune system. Progress in the treatment and management of infections during pregnancy will require further understanding of the changes to the immune system that occur during pregnancy. It is hypothesized that there is a fundamental down-regulation in the innate immune system that occurs during pregnancy and remains until delivery and that changes in serum cytokines influence na(SqrRoot) ve CD4 differentiation to different subpopulations. To that end, this study will evaluate blood samples drawn from pregnant women during early, mid, and late pregnancy and post-partum for changes in the innate immune system and compare them to data on a similar cohort of women of childbearing age from an existing database of healthy, non-pregnant women. Changes in the cytokine profile, gene expression by microarray, and in the lymphocyte and natural killer (NK) cell populations will be identified. We may perform neutrophil analysis. We will evaluate toll-like receptors functionality, and any changes in PBMC throughout pregnancy. We also plan to evaluate serum cytokine panels, PBMC by flow cytometry, and PBMC for microarray of gene expression, before and after administration of the influenza vaccine in up to 20 of the 40 pregnant subjects. Antibody levels will be measured as well. A comparison of any observed changes will be made with those previously reported for in vitro and in vivo studies.

Registry
clinicaltrials.gov
Start Date
September 30, 2011
End Date
October 11, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Changes in Cytokine profiles during pregnancy

Time Frame: 1st, 2nd, and 3rd trimesters and postpartum and postpartum

Changes in Cytokine profiles during pregnancy compared to non-pregnant control samples

Functionality of Toll-like receptors and changes in gene expression

Time Frame: 1st, 2nd, and 3rd trimesters and postpartum and postpartum

Functionality of Toll-like receptors and changes in gene expression during pregnancy during pregnancy compared to non-pregnant control samples \[Time Frame: 1st, 2nd, and 3rd trimesters and postpartum\]

Changes in lymphocyte and NK cell populations during pregnancy compared to non-pregnant control samples.

Time Frame: 1st, 2nd, and 3rd trimesters and postpartum and postpartum

Changes in lymphocyte and NK cell populations during pregnancy compared to non- pregnant control samples. \[Time Frame: 1st, 2nd, and 3rd trimesters and postpartum and postpartum\]

Secondary Outcomes

  • Changes in Cytokine profiles(Before and after the administration of the influenza vaccine in a subset of pregnant women)
  • Changes in lymphocyte and INK cell populations(Before and after the administration of the influenza vaccine in a subset of pregnant women)
  • Functionality of Toll-like receptors and changes in gene expression(Before and after the administration of the influenza vaccine in a subset of pregnant women)

Study Sites (1)

Loading locations...

Similar Trials